Item 5. Other Information
Item 5. Other Information
Rule 10b5-1 Trading Plans
On February 28, 2025 , Paul Blanchfield , our President , entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a “10b5-1 Plan”). The 10b5-1 Plan provides for the potential sale of up to 29,271 shares of our common stock between June 5, 2025, and March 6, 2026 . Pursuant to the 10b5-1 Plan, Mr. Blanchfield will also make a gift of 659 shares of common stock on November 14, 2025.
On March 3, 2025 , Mary Anne Heino , the Chairperson of our Board , entered into a 10b5-1 Plan providing for the potential sale of shares of our common stock in an amount necessary to attain approximately net sale proceeds of $2,000,000 between June 2, 2025,
41
Table of Contents
and June 13, 2025 . The 10b5-1 Plan also provides for the potential sale of up to 70,142 shares of our common stock between August 8, 2025, and March 13, 2026.
On March 6, 2025 , Daniel Niedzwiecki , our Chief Administrative Officer, General Counsel and Corporate Secretary , entered into a 10b5-1 Plan providing for the potential sale of up to 12,000 shares of our common stock between June 5, 2025, and July 7, 2025 .
On March 10, 2025 , Julie McHugh , a member of our Board , entered into a 10b5-1 Plan providing for the potential sale of up to 5,192 shares of our common stock on June 9, 2025 .
On March 11, 2025 , Samuel R. Leno , a member of our Board , entered into a 10b5-1 Plan providing for the potential sale of up to 14,307 shares of our common stock between June 11, 2025, and November 12, 2025 .
On March 11, 2025 , Robert Marshall , our CFO and Treasurer , entered into a 10b5-1 Plan providing for the potential sale of up to 39,773 shares of our common stock between June 9, 2025, and June 30, 2025 .
42
Table of Contents
Item 6. Exhibits
INCORPORATED BY REFERENCE
EXHIBIT
NUMBER DESCRIPTION OF EXHIBITS FORM FILE
NUMBER EXHIBIT FILING
DATE
10.1*
Third Amendment to Lease dated as of February 14, 2025, by and between Lantheus Medical and 201 Burlington Road Owner, LLC
31.1* Certification of Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a).
31.2* Certification of Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a).
32.1** Certification pursuant to 18 U.S.C. Section 1350.
101.INS* Inline XBRL Instance Document
101.SCH* Inline XBRL Taxonomy Extension Schema Document
101.CAL* Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF* Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB* Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE* Inline XBRL Taxonomy Extension Presentation Linkbase Document
104* Cover Page Interactive Data File (embedded within the Inline XBRL document)
* Filed herewith.
** Furnished herewith.
43
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
LANTHEUS HOLDINGS, INC.
By: /s/ BRIAN MARKISON
Name: Brian Markison
Title: Chief Executive Officer
(Principal Executive Officer)
Date: May 7, 2025
LANTHEUS HOLDINGS, INC.
By: /s/ ROBERT J. MARSHALL, JR.
Name: Robert J. Marshall, Jr.
Title: Chief Financial Officer and Treasurer
(Principal Financial Officer)
Date: May 7, 2025
44
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.